BAY14-2222 Prophylaxis and Joint Function Improvement (Adults)

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions

Hematologic DiseaseHemophilia A

Interventions

DRUG

Kogenate (BAY14-2222)

One group two treatment schedules, first on-demand then switch to prophylaxis

Trial Locations (11)

Pavia

Chapel Hill

Madrid

Santa Cruz de Tenerife

Florence

Strasbourg

Houston

Aurora

Roma

Cardiff

Sheffield